biomedicina slovenica


pr=Cvelbar : 85

  1. Rener-Sitar Ksenija; Junkar Ita; Cvelbar Uroš; Mozetič Miran
    Metoda za izboljšanje vezave dentalne silikatne keramike s kompozitnimi cementi
    2020
  2. Kos Špela; Čemažar Maja; Filipič Gregor; Serša Gregor; Cvelbar Uroš
    Skin damage caused by atmospheric pressure helium plasma jet treatment
    2017
  3. Kos Špela; Blagus Tanja; Čemažar Maja; Filipič Gregor; Serša Gregor; Cvelbar Uroš
    Safety aspects of atmospheric pressure helium plasma jet operation on skin
    2017
  4. Kos Špela; Čemažar Maja; Filipič Gregor; Serša Gregor; Cvelbar Uroš
    Safety aspects of atmospheric pressure helium plasma jet operation on mouse skin
    2017
  5. Cvelbar Mirjam; Hočevar Marko; Novaković Srdjan; Stegel Vida; Perhavec Andraž; Krajc Mateja
    Genetic counselling, BRCA1/2 status and clinico-pathologic characteristics of patients with ovarian cancer before 50 years of age
    2017
  6. Kos Špela; Hojnik Nataša; Modic Martina; Čemažar Maja; Serša Gregor; Cvelbar Uroš
    Safety level of atmospheric pressure jet skin treatment
    2016
  7. Kralj Tina; Cvelbar Judita; Markoli Sabina; Terlević Dabić Diana; Sajko Gorazd
    Uradno določene zgornje meje nimamo
    2015
  8. Kos Špela; Cvelbar Uroš; Blagus Tanja; Čemažar Maja; Serša Gregor
    Safety level of helium plasma treatment
    2015
  9. Recek Nina; Cheng Xiaoqian; Keidar Michael; Cvelbar Uroš; Vesel Alenka; Mozetič Miran; Sherman Jonathan H.
    Effect of cold plasma on glial cell morphology studied by atomic force microscopy
    2015
  10. Cvelbar Martina; Čufar Andreja
    Pogovor z veliko začetnico
    2007
  11. Kucharcyzk Pavel; Otgonyu Onon; Kitano Takeshi; Gregorova Adriana; Kreuh Darij; Cvelbar Uroš; Sedlarik Vladimir; Saha Petr
    Correlation of morphology and viscoelastic properties of partially biodegradable polymer blends based on polyamide 6 and polylactide copolyester
    2012
  12. Žakelj-Mavrič Marija; Cvelbar Damjana; Žist Vanja; Kobal Katja; Žigon Dušan
    Steroid toxicity and detoxification in fungi
    2012
  13. Cvelbar Damjana; Žist Vanja; Kobal Katja; Žigon Dušan; Žakelj-Mavrič Marija
    Steroid toxicity and detoxification in fungi
    2012
  14. Cvelbar M; Hočevar M; Vidmar G; Teugels E
    BRCA1/2 status and clinicopathologic characteristics of patients with double primary breast and ovarian cancer
    2011
  15. Mehle Nataša; Milavec Mojca; Dreo Tanja; Camloh Marjana; Ravnikar Maja; Mavsar Simona; Knapič Vlasta; Miklič-Lautar Irena; Jerman-Cvelbar Joži
    Introduction of GM potato for scientific purpose to a laboratory in Slovenia
    2009
  16. Mehle Nataša; Dreo Tanja; Camloh Marjana; Ravnikar Maja; Mavsar Simona; Knapič Vlasta; Miklič-Lautar Irena; Jerman-Cvelbar Joži
    Introduction of organisms for scientific purposes to Slovenia
    2009
  17. Potočnik Andrej; Jerman Cvelbar Joži; Širca Saša; Urek Gregor
    Posebni nadzor krompirjevih ogorčic Globodera rostochiensis in G. pallida in fitosanitarni ukrepi
    [Survey of potato cyst nematodes Globodera rostochiensis and G. pallida and phytosanitary measures]
    2009
  18. Cvelbar Mirjam; Uršič-Vrščaj Marjetka; Rakar Stelio
    Ali je BRCA1-2 mutacija pri bolnicah z dvojnim primarnim rakom jajčnikov in dojk vedno prisotna?
    2006
  19. Cvelbar M; Uršič-Vrščaj M; Rakar S
    Risk factors and prognostic factors in patients with double primary cancer: epithelial ovarian cancer and breast cancer
    2005
  20. Cvelbar Mirjam; Uršič-Vrščaj Marjetka; Rakar Stelio
    Dvojni primarni rak jajčnikov in dojk: dejavniki tveganja in napovedni dejavniki
    2005
  21. Cvelbar Martina
    Novosti 4. izdaje Evropske farmakopeje v letu 2003
    [New contents of the 4th European pharmacopoeia in 2003]
    2003
  22. Cvelbar M; Kočevar-Nared J
    Kontrola kakovosti krvnih izdelkov v Republiki Sloveniji
    2004
  23. Kostnapfel-Rihtar Tatja; Kerstin-Petrič Vesna; Cvelbar Renata; Vrančič Martin; Šoltes Vera
    Medresorska problematika
    1995
  24. Cvelbar Martina; Kočevar-Nared Jasna
    Kontrola kakovosti krvnih izdelkov v Republiki Sloveniji
    [Quality control of human blood products in Republic of Slovenia]
    2004
  25. Apih Tomaž; Lahajnar Gojmir; Sepe Ana; Blinc Robert; Milia Fani; Cvelbar Robert; Emri Igor; Gusev Boris V; Titova Larisa A
    Proton spin-lattice relaxation study of the hydration of self-stressed expansive cement
    2001
  26. Cvelbar Franc
    Fizikalne količine in enote
    2003
  27. Cvelbar Mirjam
    Dejavniki tveganja in napovedni dejavniki pri bolnicah z dvojnim primarnim rakom: epitelnim rakom jajčnika in rakom dojke
    2003
  28. Cvelbar Gorazd
    Telesna aktivnost in šport kot prvina kakovosti življenja sladkornih bolnikov
    1999
  29. Cvelbar Gorazd
    Telesna aktivnost in šport kot prvina kakovosti življenja sladkornih bolnikov
    1999
  30. Cvelbar Gorazd
    Telesna aktivnost in šport kot prvina kakovosti življenja sladkornih bolnikov
    1999
  31. Cvelbar M
    Tretja izdaja Evropske farmakopeje (Ph. Eur. 3rd Ed.)
    1997
  32. Peternel P; Cvelbar-Marinko T; Goršič-Tomažič K; Stegnar M; Salobir-Pajnič B; Uhrin P; Binder BR
    Activated protein C resistance among patients with deep vein thrombosis in Slovenia
    1996
  33. Uran Apolonija; Krbavčič Aleš; Cvelbar Martina
    Vrečke za kri in krvne sestavine
    [Containers for blood and blood components]
    2001
  34. Cvelbar Martina; Šmid-Korbar Jelka; Budihna Metka
    Farmacevtski zakoniki: Evropska farmakopeja in Formularium Slovenicum z dopolnili
    [Pharmaceutical legislation: European pharmacopoeia and Formularium Slovenicum with supplements]
    2003
  35. Doupona-Topič Mojca; Cvelbar Gorazd; Matoh Janez
    Športna dejavnost - "Recept za zdravo življenje"
    [Sport activity - "A prescription for healthy life"]
    2002
  36. Cvelbar Martina
    Delo izvedencev pri Evropski farmakopeji: delovanje izvedenske skupine št. 6B: krvni izdelki
    2001
  37. Cvelbar Martina
    Novosti 4. izdaje Evropske farmakopeje
    2001
  38. Cvelbar Martina; Šmid-Korbar Jelka; Petek Nežka; Rudolf Martina; Budihna Metka
    Komentar ob izidu Slovenskega dodatka k evropski farmakopeji z drugim dopolnilom
    [A comment of the publication of Formularium Slovenicum with second annex]
    2001
  39. Uran Apolonija; Krbavčič Aleš; Cvelbar Martina
    Diethylhexylphthalate in blood bags
    2001
  40. Marinko Petra; Byrne-Habič Barbara B; Cvelbar Martina; Krbavčič Aleš
    Optimisation of polycrylamide gel electrophoresis as a method for the identifiaction and purity determination of recombinant human interferon alpha2 in pharmaceutical products
    [Optimizacija metode poliakrilamidne gelske elektroforeze za identifikacijo in določanje čistoče rekombinantnega človeškega interferona alfa2 v farmacevtskih izdelkih]
    2000
  41. Čufar Andreja; Cvelbar Martina; Dolinar Jelka; Frankič Darja; Hladnik Gorazd; Primožič Stanislav
    Posvet Samozdravljenje: možnosti in perspektive samozdravljenja; 2001 mar 23; Brdo pri Kranju
    2001
  42. Cvelbar P; Kopitar Z
    Načrtovanje preparata z upočasnjenim sproščanjem - prikazano na primeru Redergin
    1984
  43. Kopitar Z; Lenardič A; Cvelbar P; Urbančič-Smerkolj J; Čulig J
    Estimation of absolute biovailability of DHESN on healthy volunteers
    1985
  44. Stanulović M; Lenardič A; Cvelbar P; Žorž M; Milovac J; Kopitar Z
    Vergleichende Untersuchungen von zwei Dihydroergotoxin-Zubereitungen
    1985
  45. Stanulović M; Lenardič A; Cvelbar P; Žorž M; Milovac J; Kopitar Z
    Vergleichende Untersuchungen von zwei Dihydroergotoxin-Zubereitungen
    1985
  46. Kopitar Z; Milovac J; Lenardič A; Cvelbar P; Žorž M; Čulig J
    Bioavailability of nifedipine in various pharmaceutical formulations
    1985
  47. Kopitar Z; Lenardič A; Cvelbar P; Urbančič-Smerkolj J; Čulig J
    Estimation of absolute bioavailability of DHESN on healthy volunteers
    1985
  48. Cvelbar P; Lenardič A; Mohar M; Žorž M; Antolič G; Janežič A
    Bioequivalence of two different galenic formulations containing chloroquine
    1985
  49. Cvelbar P; Kopitar Z
    Statistical methods for comparative bioavailability studies
    1985
  50. Cvelbar P; Lenardič A; Kopitar Z; Vrhovac B; Milivojević D; Žorž M
    Prediction of optimal dosage regimen for urinary tract antiseptics
    1983
  51. Lenardič A; Cvelbar P; Kopitar Z
    Farmakokinetika večkratnega doziranja pipemidinske kisline
    1984
  52. Kopitar Z; Cvelbar P; Vrhovac B; Lenardič A; Žorž M
    Primerjava biološke uporabnosti dveh preparatov pipemidinske kisline na prostovoljcih
    1984
  53. Cvelbar P; Lenardič A; Kopitar Z; Vrhovac B; Pavšič F
    Bioequivalence and pharmacokinetics of two drug products of pipemidic acid
    1982
  54. Cvelbar P; Kopitar Z; Lenardič A; Jakovljević V; Stanulović M
    BIOAVAILABILITY STUDY OF A CIMETIDINE PREPARATION IN VOLUNTEERS
    1982
  55. Lenardič A; Cvelbar P; Kopitar Z; Kozjek F
    KINETICS OF CIMETIDINE (ALTRAMENT) AFTER ORAL AND PARENTERAL APPLICATION
    1982
  56. Kopitar Z; Vrhovac B; Žorž M; Lenardič A; Cvelbar P
    PHARMACOKINETICS AND BIOVAILABILITY OF REDERGIN
    1982
  57. Kopitar Z; Cvelbar P; Vrhovac B; Grims M
    BIOLOŠKA UPOTREBLJIVOST DVIJU RAZLIčITIH FORMULACIJA CIMETIDIN TABLETA
    1981
  58. Cvelbar P
    VEZAVA UčINKOVIN NA PLAZEMSKE BELJAKOVINE (SULFANILAMIDI IN ANTIBIOTIKI)
    1978
  59. Cvelbar Mirjam; Kralj Božo
    Zgodnje odkrivanje epitelnega karcinoma jajčnika: analiza podatkov operiranih bolnic na Ginekološki kliniki v Ljubljani v obdobju 1996-1997
    [Early detection of epithelial ovarian cancer: analysis of the data of the patients operated at Department of gynecology and obstetrics in Ljubljana during 1996-1997]
    2001
  60. Cvelbar Martina
    Uveljavljanje evropske farmakopije v Sloveniji
    [Implementation of European pharmacopoeia in Slovenia]
    2000
  61. Knapič Vlasta; Celar Mojca; Groznik Katarina; Potočnik Andrej; Jerman-Cvelbar Joži; Pečnik Marina; Ravnikar Maja; Dolničar Peter; Južnik Marjan
    Report No 2 on surveillance of potato brown rot and ring rot in Slovenia (June 1999 - May 2000)
    2000
  62. Cvelbar Martina; Krbavčič Aleš; Dobrovšak-Sourek Vlasta
    Correlation between liquid chromatography size-exclusion chromatography and Kjedahl method for determination of protein content in I. V. immunoglobulin fractions
    1995
  63. Groznik Katarina; Knapič Vlasta; Perme Simona; Urek Gregor; Jerman-Cvelbar Joži; Miklič-Lautar Irena; Ravnikar Maja
    Aide memoire for TAIEX advisory visits to the associated countries concerning plant health and plant protection products
    1999
  64. Groznik Katarina; Knapič Vlasta; Remmerswaal Mojca; Jerman-Cvelbar Joži; Potočnik Andrej; Benko-Beloglavec Anita; Maček Janez; Ravnikar Maja; Dolničar Peter
    Potato Brown rot and Ring rot in Slovenia
    1999
  65. Cvelbar M
    Tretja izdaja evropske farmakopeje (Ph. Eur. 3rd ed.)
    1997
  66. Stegnar M; Peternel P; Uhrin P; Cvelbar-Marinko T; Goršič-Tomažič K; Binder BR
    Fibrinolysis in patients with the 1691 G-A mutation in factor V gene and history of deep vein thrombosis
    1997
  67. Panjan P; Navinšek B; Cvelbar A; Zalar A; Vlcek J
    High-temperature oxidation of Tin/CrN multilayers reactively sputtered at low temperatures
    1998
  68. Panjan P; Navinšek B; Cvelbar A; Zalar A; Milošev I
    Oxidation of TiN, ZrN, TiZrN, CrN, TiCrN and TiN/CrN multilayer hard coatings reactively sputtered at low temperature
    1996
  69. Cvelbar-Marinko Tanja; Goršič-Tomažič Karmen
    Pogostnost neodzivnosti na aktivirani protein C pri bolnikih z vensko trombozo
    [Incidence of activated protein C resistance among patients with deep vein thrombosis]
    1997
  70. Opara J; Primožič S; Cvelbar P
    Prediction of pharmacokinetic parameters and their variability in bioavailability studies by artificial neural networks
    1997
  71. Prodan Tomaž; Andlovic Jože; Bajič Marino; Cvelbar Renata; Romih Matjana
    Enotni elementi informacijskega sistema v centrih za socialno delo
    1994
  72. Cvelbar P; Bren A; Lenardič A; Prošek M; Lukša J; Žorž M
    Effect of the dosage form on the pharmacokinetic characteristics of amoxicillin/clavulanic acid combination
    1996
  73. Cvelbar M
    Nadzor kakovosti in varnost biotehnoloških farmacevtskih izdelkov
    [Quality control and relevant safety of biotechnological medicinal products]
    1996
  74. Cvelbar M
    Kakovostni in varnostni vidik uporabe biotehnoloških zdravilnih učinkovin
    [Quality and safety aspect of biotechnology products]
    1995
  75. Karič E; Žabkar A; Cvelbar A; Panjan P; Ambrožič M; Marinkovič V; Mandrino D; Poberaj I; Gasperič J; Navinšek B
    YBaCuO superconducting thin films sputtered in a triode system
    1990
  76. Navinšek B; Panjan P; Cvelbar A
    Characterization of low temperature CrN and TiN (PVD) hard coatings
    1995
  77. Cvelbar A; Panjan P; Navinšek B; Zalar A
    A continuous electrical resistivity measurement in thin films
    1994
  78. Cvelbar P; Mrhar A; Karba R; Kopitar Z
    Modeling and simulation approach in studying influence of saturable kinetics on first-pass
    1991
  79. Eržen J; Cvelbar P; Miličič M
    Etodolak - novi predstavnik iz skupine nesteroidnih protivnetnih zdravil
    [Etodolac - new representative of nonsteroidal anti-inflammatory drug]
    1992
  80. Cvelbar F
    Izotopsko ionizirajoče sevanje v medicini - fizikalne osnove
    1992
  81. Varl J; Lenardič A; Cvelbar P; Kopitar Z; Benedik M; Drinovec J
    Enkratno dnevno odmerjanje pefloksacina
    [Pefloxacin once-daily dosage regimen]
    1990
  82. Kopitar Z; Cvelbar P; Žorž M; Milutinović S; Janković N
    Pharmacokinetics of ranitidine in adult patients with end stage renal disease after single and multiple dosing
    1987
  83. Cvelbar P; Čulig J; Kopitar Z; Lenardič A; Urbančič-Smerkolj J; Žorž M
    Bioavailability of dihydroergosine in healthy volunteers
    1987
  84. Cvelbar P
    Načrtovanje zdravilnih oblik z upočasnjenim sproščanjem
    1987
  85. Kopitar Z; Vrhovac B; Lenardić A; Cvelbar P; Žorž M; Francetić I
    Dose dependent bioavailability of propranolol
    1986


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics